Open-label Study of Safety and Tolerability of Memantine in Children With Autism

Completed · Phase 2

Conditions studied: Autism, Pediatric Autism

In brief

The purpose of this study is to evaluate the long-term safety and tolerability of memantine in the treatment of autism in pediatric patients.

Key facts

Study ID

NCT01999894

Run by

Forest Laboratories

People needed

102

Starts

2009-11-01

Expected to finish

2013-02-01

Last updated by the study team

2014-03-18

Who can join

Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed lead-in study MEM-MD-57A (NCT00872898)
• A knowledgeable caregiver capable of providing reliable information about the patient's condition, able to attend all clinic visits with the patient

You may not qualify if…

• Patients with a concurrent medical condition that might interfere with the conduct of the study

Where it is running

• Forest Investigative Site 005 — Phoenix, Arizona, United States
• Forest Investigative Site 003 — Sacramento, California, United States
• Forest Investigative Site 021 — San Francisco, California, United States
• Forest Investigative Site 026 — Santa Ana, California, United States
• Forest Investigative Site 020 — Santa Ana, California, United States
• Forest Investigative Site 002 — Stanford, California, United States
• Forest Investigative Site 024 — Jacksonville Beach, Florida, United States
• Forest Investigative Site 007 — St. Petersburg, Florida, United States
• Forest Investigative Site 014 — Hoffman Estates, Illinois, United States
• Forest Investigative Site 023 — Naperville, Illinois, United States
• Forest Investigative Site 010 — Indianapolis, Indiana, United States
• Forest Investigative Site 025 — Cambridge, Massachusetts, United States
• Forest Investigative Site 011 — Toms River, New Jersey, United States
• Forest Investigative Site 006 — Voorhees Township, New Jersey, United States
• Forest Investigative Site 017 — Manhasset, New York, United States
• Forest Investigative Site 013 — Cleveland, Ohio, United States
• Forest Investigative Site 015 — Cleveland, Ohio, United States
• Forest Investigative Site 001 — Columbus, Ohio, United States
• Forest Investigative Site 019 — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.